Measurement of Energy Metabolism in Infants
BabyEE Pilot
2 other identifiers
observational
70
1 country
1
Brief Summary
The purpose of this study is to measure energy expenditure during the first 3 months of life in infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2016
CompletedFirst Posted
Study publicly available on registry
February 17, 2016
CompletedStudy Start
First participant enrolled
March 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
March 18, 2026
March 1, 2026
11.3 years
January 14, 2016
March 16, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Energy Expenditure by infant metabolic chamber
Energy expenditure by infant metabolic chamber measured twice about 1 week apart for test re-test reliability in infants aged 1-3 months.
Approximately 1 week
Energy expenditure by doubly labeled water
Energy expenditure by doubly labeled water measured over approximately 7 days in infants aged 1-3 months
Approximately 1 week
Secondary Outcomes (2)
Percent body fat
Approximately 1 week
Physical activity counts
Approximately 1 week
Study Arms (1)
Infants
Infants aged 1-3 months
Eligibility Criteria
Full-term infants aged 1 to 3 months who are exclusively fed breast milk and/or infant formula will be recruited
You may qualify if:
- Healthy, full-term infant
- Aged 1 month (28 days) to 3 months (12 weeks, 6 days) at the first visit
- Exclusively fed breast milk and/or infant formula
- Willing to accept doubly-labeled water
You may not qualify if:
- Unable to complete 3 clinic visits within about 14 days at Pennington Biomedical Research Center
- Born preterm (\< 37 weeks gestation)
- Congenital abnormality or disability
- Gastric reflux
- Acute illness within 7 days of the study (fever, diarrhea)
- Use of medications to treat a chronic condition (does not include use of vitamin supplements or PRN medication for flatulence or reflux such as Pepcid)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Leanne M Redman, Ph.D.
Pennington Biomedical Research Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 14, 2016
First Posted
February 17, 2016
Study Start
March 16, 2016
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
March 18, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share